Fox Run Management, L.L.C. Harmony Biosciences Holdings, Inc. Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$218 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$156 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$75.2 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$52.2 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.95B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...